Company intelligence / Profile preview

HydraMed

Fort Lauderdale, Florida, United Stateshydramed.com ↗

Ownership: Private
Development stage: Commercial

Overview

HydraMed provides mobile IV therapy and telemedicine-driven personalized health solutions. Their clinical results are not published in peer-reviewed journals; the company claims high customer satisfaction with over 5,000 five-star reviews for their mobile IV hydration and wellness products. They emphasize safety through licensed medical professionals but do not offer FDA-approved drugs for disease treatment[1][2][3].

Therapeutic areas: Metabolic DisordersEndocrinologyImmunologyOther
Modalities: Device (IV infusion)Small molecule (compounded medications such as tirzepatide, semaglutide)Peptides (specialized peptide therapies)
Industry: Non-Academic Healthcare

Beyond the preview

Go deeper on HydraMed.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on HydraMed.

Explore the full profile